|
|
|
|
|
|
|
|
*ACTION* *ACTION**ACTION**ACTION*
HOW YOU CAN HELP |
|
Send this information to your friends, family and associates and ask them to do the same. |
|
|
|
|
(The senate uses web-forms with fields) Use “Health” or “Other” in the subject field”)
Support is appreciated in your own words, or a suggested wording is below, which you can copy and paste.
|
Dear Senator,
I am a voter in your state. I am very troubled by the situation described at http://www.helpfortony.org/Anthony_Viscosi.pdf. I expect you will take the time to look into this situation.
This man is dying because of the negligence and irresponsibility of Johnson & Johnson following a clinical trial for Stelara, in which Mr. Viscosi participated. Neither Johnson & Johnson nor the FDA has offered any help whatsoever to this man as his health deteriorates.
Please contact Johnson & Johnson’s CEO, Alex Gorsky at (732) 524-0400 and express your expectation that Johnson & Johnson will make good its written promise to Mr. Viscosi (as presented when he entered its clinical trial program) to fully support him in case of adverse event, and will also follow the Johnson & Johnson corporate Credo, Paragraph 4: “Research must be carried on, innovative programs developed and mistakes paid for.” The Credo was personally written by the leader of the company in 1943; Mr. Gorsky spent a full 30 minutes orating in detail about the Credo at his annual shareholder meeting on April 26th, 2012.
Please contact Anthony Viscosi personally at helpfortony@helpfortony.org to express your support.
A catastrophic mistake was made with Mr Viscosi. It needs to be remedied. Thank you for your service.
Sincerely, Voter |
|
|
|
SME Statements
It appears that the mistake was to give the most powerful psoriatic drug ever made to someone who had very mild psoriasis" - PK, PMP |
"The Documented Clinical Trial Exclusion: "Any non-plaque psoriasis" is the certification that this patient had no other type of psoriasis in his history, prior to this clinical trial. If there had been, he would have been disqualified." - EV, PI |
"Without specific clinical data, that only the drug's developers can provide, there is little hope that an effective treatment plan can be developed." - BO, MD |
|
|
|
|
|